India to Australia: Dasatinib Export Trade Route
India has recorded 20 verified shipments of Dasatinib exported to Australia, representing a combined trade value of $2.1M USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $106.0K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 38% of total export value with 4 shipments worth $808.0K USD. On the buying side, SUN PHARMA ANZ PTY LTD. is the largest importer in Australia with $682.5K USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, DR REDDY S LABORATORIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED — together control 67% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Australia Dasatinib corridor is one of India's established pharmaceutical export routes, with 20 shipments documented worth a combined $2.1M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 38% of all export value, reflecting the consolidated nature of India's dasatinib manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $106.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with dasatinib's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 12.8%, placing it at rank #8 among India's top dasatinib export destinations globally.
On the import side, key buyers of Indian dasatinib in Australia include SUN PHARMA ANZ PTY LTD., SUN PHARMA ANZ PTY LTD, DR REDDYS LABORATORIES (AUSTRALIA) and 5 others. SUN PHARMA ANZ PTY LTD. is the single largest importer with 3 shipments valued at $682.5K USD.
Route Characteristics
- Average transit18 days
- Peak seasonQ1
- Primary modeSea freight
- Top portHYDERABAD ACC (INHYD4)
Market Position
- Global rank#8
- Annual growth+12.8%
- Demand growth+13.2%
- Regulatory ease89/100
Top 10 Indian Dasatinib Exporters to Australia
Showing top 10 of 7 Indian suppliers exporting Dasatinib to Australia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $202.0K per shipment | 4 | $808.0K | 38.1% |
| 2 | DR REDDY S LABORATORIES LIMITED Avg $159.8K per shipment | 2 | $319.6K | 15.1% |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $74.4K per shipment | 4 | $297.5K | 14.0% |
| 4 | DR.REDDY'S LABORATORIES LTD Avg $87.6K per shipment | 3 | $262.7K | 12.4% |
| 5 | SUN PHARMACEUTICAL INDUSTRIES LTD Avg $85.1K per shipment | 3 | $255.3K | 12.0% |
| 6 | DR.REDDY'S LABORATORIES LTD Avg $44.9K per shipment | 3 | $134.6K | 6.3% |
| 7 | MSN LABORATORIES PRIVATE LIMITED Avg $41.9K per shipment | 1 | $41.9K | 2.0% |
This table shows the top 10 of 7 Indian companies exporting dasatinib to Australia, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED, DR REDDY S LABORATORIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , DR.REDDY'S LABORATORIES LTD , SUN PHARMACEUTICAL INDUSTRIES LTD, DR.REDDY'S LABORATORIES LTD, MSN LABORATORIES PRIVATE LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 4 shipments worth $808.0K USD, giving it a 38% market share. The top 3 suppliers together account for 67% of the total trade value on this route.
Top 10 Dasatinib Importers in Australia
Showing top 10 of 8 known buyers in Australia receiving Dasatinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian dasatinib in Australia include SUN PHARMA ANZ PTY LTD., SUN PHARMA ANZ PTY LTD, DR REDDYS LABORATORIES (AUSTRALIA), SUN PHARMA ANZ PTY LTD , DR.REDDY'S LABORATORIES (AUSTRALIA) , among 8 total buyers. The largest importer is SUN PHARMA ANZ PTY LTD., accounting for $682.5K USD across 3 shipments — representing 32% of all dasatinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMA ANZ PTY LTD. | 3 | $682.5K | 32.2% |
| 2 | SUN PHARMA ANZ PTY LTD | 4 | $380.9K | 18.0% |
| 3 | DR REDDYS LABORATORIES (AUSTRALIA) | 4 | $364.5K | 17.2% |
| 4 | SUN PHARMA ANZ PTY LTD | 4 | $297.5K | 14.0% |
| 5 | DR.REDDY'S LABORATORIES (AUSTRALIA) | 2 | $248.0K | 11.7% |
| 6 | DR REDDY S LABORATORIES AUSTRALIA | 1 | $89.6K | 4.2% |
| 7 | SANDOZ PTY LTD | 1 | $41.9K | 2.0% |
| 8 | DR REDDYS LABORATORIES (AUSTRALIA), | 1 | $14.7K | 0.7% |
Top 10 Dasatinib Formulations Imported by Australia
Showing top 10 of 20 product formulations shipped on the India to Australia Dasatinib route, ranked by trade value
Australia imports a wide range of dasatinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — DASATINIB SUN FC TAB 100MG 30BTL AU(Dasatinib Tablets 100 mg) Bt:HAG0627A MFD:17.03.2025 EXP: 29.02.2028(PACK:30 TABLET) — accounts for $355.2K USD across 1 shipments. There are 20 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DASATINIB SUN FC TAB 100MG 30BTL AU(Dasatinib Tablets 100 mg) Bt:HAG0627A MFD:17.03.2025 EXP: 29.02.2028(PACK:30 TABLET) | 1 | $355.2K | 16.8% |
| 2 | DASATINIB DR.REDDYS TAB100 MG (30 S PACK) (QTY: 1515 X 30 = 45450) | 1 | $230.0K | 10.8% |
| 3 | DASATINIB SUN FC TAB 20MG 60BTL AU (Dasatinib Tablets 20 mg)Bt:HAG0685A MFD:17.03.2025 EXP:29.02.2028 PACK : 60s Bottle | 1 | $198.1K | 9.3% |
| 4 | DASATINIB SUN FC TAB 100MG 30BTL AU PACK | 1 | $172.6K | 8.1% |
| 5 | DASATINIB DR.REDDY'S TAB 100MG 30S | 1 | $133.5K | 6.3% |
| 6 | DASATINIB SUN FC TAB 70MG 60BTL AU Batch: HAG0686A MFD : 17.03.2025 EXP : 29.02.2028 PACK : 60s Bottle | 1 | $129.2K | 6.1% |
| 7 | DASATINIB SUN FC TAB 50MG 60BTL AU PACK 60S BOTTLE BATCH DETAILS AS PER INVOICE | 1 | $125.6K | 5.9% |
| 8 | DASATINIB DR. REDDY'S TAB 100MG 30'S (63 | 1 | $114.5K | 5.4% |
| 9 | DASATINIB SUN FC TAB 100MG 30BTL AU,BATCH : HAE1765B MFD : 20.07.2023 EXP : 30.06.2026 | 1 | $105.2K | 5.0% |
| 10 | DASATINIB DR REDDY S TAB 70MG 60S 400X60 S PACK 24000 NOS | 1 | $89.6K | 4.2% |
Showing top 10 of 20 Dasatinib formulations imported by Australia on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 85%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD ACC (INHYD4) handles the highest volume with 7 shipments. Transit time averages 18 days by sea.
Market Dynamics
India's dasatinib exports to Australia are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, DR REDDY S LABORATORIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED — together account for 67% of total trade value on this route. The average shipment value of $106.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as dasatinib dr.reddys tab100 mg (30 s pack) (qty: 1515 x 30 = 45450) and dasatinib sun fc tab 20mg 60btl au (dasatinib tablets 20 mg)bt:hag0685a mfd:17.03.2025 exp:29.02.2028 pack : 60s bottle, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, SUN PHARMA ANZ PTY LTD. is the largest importer with 3 shipments worth $682.5K USD — representing 32% of all dasatinib imports from India on this route. A total of 8 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $2.1M
- Avg. Shipment
- $106.0K
- Suppliers
- 7
- Buyers
- 8
- Transit (Sea)
- ~18 days
- Annual Growth
- +12.8%
Other Dasatinib Routes
Unlock the Full India to Australia Dasatinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 20 shipments on this route.
Frequently Asked Questions — India to Australia Dasatinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Dasatinib to Australia?
The leading Indian exporters of Dasatinib to Australia are SUN PHARMACEUTICAL INDUSTRIES LIMITED, DR REDDY S LABORATORIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED . SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 38% of total trade value on this route.
Q What is the total value of Dasatinib exports from India to Australia?
India exports Dasatinib to Australia worth approximately $2.1M USD across 20 recorded shipments. The average value per shipment is $106.0K USD.
Q Which ports does India use to ship Dasatinib to Australia?
The most active port of origin is HYDERABAD ACC (INHYD4) with 7 shipments. Indian exporters primarily use sea freight for this route, with 85% of shipments going by sea and 30% by air.
Q How long does shipping take from India to Australia for Dasatinib?
The average transit time for Dasatinib shipments from India to Australia is approximately 18 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Australia Dasatinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 12.8% with demand growth tracking at 13.2%. The route is ranked #8 among India's top Dasatinib export destinations globally.
Q How many suppliers are active on the India to Australia Dasatinib route?
There are currently 7 active Indian suppliers exporting Dasatinib to Australia. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 38% of total shipment value.
Q Who are the main importers of Dasatinib from India in Australia?
The leading importers of Indian Dasatinib in Australia include SUN PHARMA ANZ PTY LTD., SUN PHARMA ANZ PTY LTD, DR REDDYS LABORATORIES (AUSTRALIA), SUN PHARMA ANZ PTY LTD , DR.REDDY'S LABORATORIES (AUSTRALIA) . SUN PHARMA ANZ PTY LTD. is the largest buyer with 3 shipments worth $682.5K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Australia export trade corridor identified from Indian Customs (DGFT) records for Dasatinib.
- 2.Supplier/Buyer Matching: 7 Indian exporters and 8 importers in Australia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 20 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
20 Verified Shipments
7 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists